BLOG | Alphawatch

top of page

HOME
BLOG
ABOUT
More

Use tab to navigate through the menu items.

All Posts
Real Estate
Biotech & Healthcare
LifeSci Weekly Updates
Macro Views
Volatility Investing and the VIX
Videos
Robotics & Automation
Municipal Bonds
Riffin' on Real Estate Recordings
Dr. is IN Monthly Call Recordings

Argenx Receives FDA Approval Causing Stock to Jump and Alnylam Shows Positive Results Boosting Its Price as the XBI Index Moves Above Its 50-Day Average

Jonathan Poyer

Jun 26, 20242 min read

LifeSci Weekly Updates

Argenx Receives FDA Approval Causing Stock to Jump and Alnylam Shows Positive Results Boosting Its Price as the XBI Index Moves Above Its 50-Day Average

Abbvie Partners with FutureGen in $150M Upfront Deal with Additional $1.56B in Potential Additional Milestones

Jonathan Poyer

Jun 18, 20242 min read

Biotech & Healthcare

Abbvie Partners with FutureGen in $150M Upfront Deal with Additional $1.56B in Potential Additional Milestones

CPI Delivers and the Bond Market Takes Notice. Investors Likely to Follow

Jonathan Poyer

Jun 13, 20241 min read

CPI Delivers and the Bond Market Takes Notice. Investors Likely to Follow

Solid CPI Bumps Biotech Index Up 1.47%. Can the Risk-On Mentality Move Beyond NVIDIA?

Jonathan Poyer

Jun 13, 20242 min read

Biotech & Healthcare

Solid CPI Bumps Biotech Index Up 1.47%. Can the Risk-On Mentality Move Beyond NVIDIA?

June 2024 Riffin' on Real Estate

Jonathan Poyer

Jun 12, 20241 min read

Riffin' on Real Estate Recordings

June 2024 Riffin' on Real Estate

Biotech M&A Continues Chugging Along. Five, Billion Dollar Plus Transactions in May. 2024 Outpacing 2023 Significantly

Jonathan Poyer

Jun 7, 20241 min read

Biotech & Healthcare

Biotech M&A Continues Chugging Along. Five, Billion Dollar Plus Transactions in May. 2024 Outpacing 2023 Significantly

Impressive Data Sets from Big Pharma and Merck Spends $1.3B to Acquire Eyebiotech

Jonathan Poyer

Jun 6, 20242 min read

Biotech & Healthcare

Impressive Data Sets from Big Pharma and Merck Spends $1.3B to Acquire Eyebiotech

Asahi Kasei announces the acquisition of Calliditas Therapeutics (CALT) for $1.1 billion. The M&A Train Never Stops!

Jonathan Poyer

Jun 3, 20242 min read

LifeSci Weekly Updates

Asahi Kasei announces the acquisition of Calliditas Therapeutics (CALT) for $1.1 billion. The M&A Train Never Stops!

May 2024 Follow-Up with the Doctor

Jonathan Poyer

May 30, 20241 min read

Dr. is IN Monthly Call Recordings

May 2024 Follow-Up with the Doctor

Biotech Capital Market Environment Highlights - Earnings Season Wrapping Up with JNJ and Novartis Acquisitions

Jonathan Poyer

May 23, 20241 min read

Biotech & Healthcare

Biotech Capital Market Environment Highlights - Earnings Season Wrapping Up with JNJ and Novartis Acquisitions

Biotech Index Hovers Around 50-Day Moving Average Despite Low Trade Volume. J&J Acquires Proteologix for $850M, Novartis Acquires MorphoSys

Jonathan Poyer

May 22, 20242 min read

Biotech & Healthcare

Biotech Index Hovers Around 50-Day Moving Average Despite Low Trade Volume. J&J Acquires Proteologix for $850M, Novartis Acquires MorphoSys

A Quarterly Deep Dive into Residential Real Estate - Charts, Charts, and More Charts!

Jonathan Poyer

May 21, 20244 min read

A Quarterly Deep Dive into Residential Real Estate - Charts, Charts, and More Charts!

Investing in Mortgage REITs and Residential Real Estate - Book Values are Growing and Credit Has Never Been Stronger

Jonathan Poyer

May 20, 20243 min read

Investing in Mortgage REITs and Residential Real Estate - Book Values are Growing and Credit Has Never Been Stronger

Mortgage-Backed Securities (MBS) in 2024 - What to Think and How to Respond

Jonathan Poyer

May 17, 20242 min read

Mortgage-Backed Securities (MBS) in 2024 - What to Think and How to Respond

Residential Mortgage Market - A Good Place to Invest? A Safe Place? Let's Take a Look

Jonathan Poyer

May 16, 20242 min read

Residential Mortgage Market - A Good Place to Invest? A Safe Place? Let's Take a Look

Biotech Trading Around its 50-Day Moving Average - XBI Index +3.95% YTD. Novavax Spikes on Deal with Sanofi

Jonathan Poyer

May 15, 20243 min read

Biotech & Healthcare

Biotech Trading Around its 50-Day Moving Average - XBI Index +3.95% YTD. Novavax Spikes on Deal with Sanofi

2024 Doubling the Number of Biotech Transactions from 2023. The Index Waits to Respond

Jonathan Poyer

May 13, 20241 min read

Biotech & Healthcare

2024 Doubling the Number of Biotech Transactions from 2023. The Index Waits to Respond

What to Think About Commercial Real Estate? How to Know When to Take A Look

Jonathan Poyer

May 10, 20242 min read

What to Think About Commercial Real Estate? How to Know When to Take A Look

Earnings Season Continues with Lots of Beats - But Little Bounce to the Sector

Jonathan Poyer

May 8, 20243 min read

Biotech & Healthcare

Earnings Season Continues with Lots of Beats - But Little Bounce to the Sector

Earnings Season Highlights a Number of Beats but Not Enough to Raise the Index

Jonathan Poyer

May 2, 20242 min read

Biotech & Healthcare

Earnings Season Highlights a Number of Beats but Not Enough to Raise the Index

© 2022 AlphaWatch

bottom of page